semaglutide to dulaglutide conversion What is the half-life of (Glucagon-like peptide-1 (GLP-1) receptor agonist)? Insulin Therapy | Type 2

When you stop, those effects fade, hunger ramps back up, and your body gravitates toward its previous set point

Regulators and drugmakers respond The FDA has told reporters that it has received reports of gastroparesis and related intestinal issues in people using GLP-1 medicines, but the agency notes that voluntary case reports on their own cannot prove the drugs caused the problems, according to CBS News

In very severe cases, this can cause problems with dehydration, weight-loss, and malnutrition that may require hospital visits or even surgery

These can include: Nausea Diarrhea or constipation Stomach pain, bloating, or gas Heartburn or burping Loss of appetite Dizziness or fatigue Some symptoms are more severe, and they require immediate medical attention